The third quarter financial results of Aquestive Therapeutics (NASDAQ: AQST) will be revealed on Monday 4th November 2024. The big news will come out after market close, so investors can learn more about how the company is doing financially.
As per the predictions of financial analysts on Wall Street, the business is set to report an estimated per share $0.13 loss for the third quarter. Additionally, the company is projected to unveil a revenue of $12.68 million for the period.
When examining the earnings report from the corresponding quarter of the previous year, it is evident that the company showcased per-share loss of $0.03. This numbers can be credited to the company's total revenue, which amounted to an impressive $13 million during the same quarter.
Wall street analysts expect the company to generate a total revenue of $58.01 million for the entire year. Additionally, these analysts also foresee the company achieving an estimated loss of $0.46 per share for the fiscal year.
AQST has scheduled a conference call on 5th November 2024 at 08:00 AM eastern time to discuss the third quarter financial results and other related information.
Aquestive Therapeutics (AQST) experienced a trading range of $5.45 to $5.67, along with a total volume of 1.30 million shares during the day. The stock concluded Friday's regular trading session at $5.52, reflecting a rise of 0.55 percent.
